The health system entered into an agreement with Abridge and will use the company’s generative AI to address the challenges associated with clinical documentation, according to a Feb. 23 news release from Abridge.
The primary objective of the initial deployment of the technology is to alleviate the cognitive burden on clinicians, allowing them to devote more time to face-to-face patient interactions rather than being tied to computers.
Abridge also announced a $150 million series C investment, led by Lightspeed Venture Partners. Abridge recently closed out a $30 million series B funding round joined by Somerville, Mass.-based Mass General Brigham Artificial Intelligence and Digital Innovation Fund, Oakland, Calif.-based Kaiser Permanente Ventures and CVS Health Ventures.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
